Immunoglobulin variants and uses thereof
US7799900B2 · kind B2 · utility
86Cited by
36References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2005 |
| Grant date | Sep 21, 2010 |
| Priority date | — |
| Expiry date | Jul 6, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.